Research Project by Dr. Kei Kunimasa, Deputy Director of Respiratory Medicine, Selected for AMED's FY2026 'Innovative Cancer Medical Practical Application Research Project'

Key facts

  • Research Project by Dr. Kei Kunimasa, Deputy Director of Respiratory Medicine, Selected for AMED's FY2026 'Innovative Cancer Medical Practical Application Research Project'
  • The research project proposed by Dr. Kei Kunimasa of the Osaka International Cancer Institute has been selected for the FY2026 'Innovative Cancer Medical Practical Application Research Project' by the Japan Agency for Medical Research and Development (AMED).
  • Source: PR Times
  • Date: April 13, 2026

Direct answer

The research project proposed by Dr. Kei Kunimasa of the Osaka International Cancer Institute has been selected for the FY2026 'Innovative Cancer Medical Practical Application Research Project' by the Japan Agency for Medical Research and Development (AMED).

Citation
Research Project by Dr. Kei Kunimasa, Deputy Director of Respiratory Medicine, Selected for AMED's FY2026 'Innovative Cancer Medical Practical Application Research Project' (April 13, 2026), PR Times
Source
PR Times
Date
April 13, 2026
The research project proposed by Dr. Kei Kunimasa of the Osaka International Cancer Institute has been selected for the FY2026 'Innovative Cancer Medical Practical Application Research Project' by the Japan Agency for Medical Research and Development (AMED).
調査NQ 65/100出典：PR Times

📋 Article Processing Timeline

  • 📰 Published: April 13, 2026 at 14:00
  • 🔍 Collected: April 13, 2026 at 14:31 (31 min after Published)
  • 🤖 AI Analyzed: April 19, 2026 at 20:54 (150h 22m after Collected)
The Osaka International Cancer Institute is a specialized medical institution for cancer established in 1959. Under the philosophy of 'providing and developing advanced cancer medical care based on the patient's perspective,' we are engaged in providing high-quality medical care, advanced research, and human resource development. At the same time, as a prefectural designated cancer care hospital, we support cancer medical care in Osaka and strive to further develop cancer medical care by broadly contributing to society through the practice of medical care that stays close to patients and their families.

FAQ

What are the key facts in this article?

The research project proposed by Dr. Kei Kunimasa of the Osaka International Cancer Institute has been selected for the FY2026 'Innovative Cancer Medical Practical Application Research Project' by the Japan Agency for Medical Research and Development (AMED).

What is the direct answer?

The research project proposed by Dr. Kei Kunimasa of the Osaka International Cancer Institute has been selected for the FY2026 'Innovative Cancer Medical Practical Application Research Project' by the Japan Agency for Medical Research and Development (AMED).

What is the source and date?

PR Times: https://prtimes.jp/main/html/rd/p/000000002.000179627.html | April 13, 2026

Back to Newsroom (28)